Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup, Report informs referring to NDTV.
India is set to probe the claims.
The health ministry of Uzbekistan, in a statement, said that the children who died had consumed cough syrup Doc-1 Max - manufactured by Noida-based Marion Biotech.
The laboratory tests of a batch of syrups found the presence of ethylene glycol, a toxic substance, the ministry said.
It also said the syrup was given to children at home without a doctor's prescription, either by their parents or on the advice of pharmacists, with doses that exceeded the standard dose for children.
It was found that the children, before being hospitalized, took this syrup at home for 2-7 days, in doses of 2.5 to 5 ml three to four times a day, which exceeds the standard dose, the ministry said.
The syrup was used by the parents as an anti-cold remedy.
After the deaths of 18 children, Doc-1 Max tablets and syrups have been withdrawn from all pharmacies in the country, the statement said, adding that seven employees were sacked because they failed to analyze the situation in time and take steps.
A joint inquiry will be conducted by the teams of Central Drugs Standard Control Organization (CDSCO - north zone) and Uttar Pradesh Drugs Controlling and Licensing Authority, it is learnt.
They have collected the samples of Doc 1-Max cough syrup from the Noida manufacturing unit of Marion Biotech for testing.
A casualty assessment report has also been sought from Uzbekistan.